Literature DB >> 6625381

Pheochromocytoma and prazosin.

J P Nicholson, E D Vaughn, T G Pickering, L M Resnick, J Artusio, H D Kleinert, J A Lopez-Overjero, J H Laragh.   

Abstract

Prazosin was used to control the signs and symptoms of excessive alpha-adrenergic activity in four patients with pheochromocytomas. Long-term dosage requirements were predicted by the blood pressure response to a single 1-mg oral dose. However, surgical management of the pheochromocytomas was inadequate with prazosin alone, and intravenous phentolamine was required to suppress the pressor surges generated by the tumor during surgical manipulation and excision.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6625381     DOI: 10.7326/0003-4819-99-4-477

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  13 in total

Review 1.  Pheochromocytoma.

Authors:  P E Cryer
Journal:  West J Med       Date:  1992-04

Review 2.  Anaesthesia for phaeochromocytoma.

Authors:  J Pullerits; S Ein; J W Balfe
Journal:  Can J Anaesth       Date:  1988-09       Impact factor: 5.063

3.  Pheochromocytoma--recent advances in diagnosis and treatment.

Authors:  N L Benowitz
Journal:  West J Med       Date:  1988-05

4.  Pheochromocytoma.

Authors:  C Reuse; J L Vincent; C Matos; M de Rood; J Unger
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

5.  Pheochromocytoma and paraganglioma.

Authors:  Vitaly Kantorovich; Karel Pacak
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

6.  Failure of blood pressure control by a new combined alpha- and beta-blocking agent (amosulalol) in a patient with pheochromocytoma.

Authors:  T Yamaguchi; C Irisawa; H Watanabe; S Kawamura; T Nakada
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

Review 7.  Current management of hypertensive emergencies.

Authors:  J Y Garcia; D G Vidt
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

Review 8.  Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features.

Authors:  Alberto Mazza; Michela Armigliato; Maria Cristina Marzola; Laura Schiavon; Domenico Montemurro; Giorgio Vescovo; Marco Zuin; Sotirios Chondrogiannis; Roberta Ravenni; Giuseppe Opocher; Patrick M Colletti; Domenico Rubello
Journal:  Endocrine       Date:  2013-07-02       Impact factor: 3.633

9.  Pheochromocytoma in children and adolescents.

Authors:  H K Ganesh; Shrikrishna V Acharya; Joe Goerge; Tushar R Bandgar; Padma S Menon; Nalini S Shah
Journal:  Indian J Pediatr       Date:  2010-01-14       Impact factor: 1.967

10.  Phaeochromocytoma in pregnancy: a case report.

Authors:  A Atan; M Yildiz; L Aydoganli; I Gullu; Z Akalin
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.